A state of dysbiosis characterized by an alteration in the composition, diversity, or functional capacity of the commensal microbial communities residing within the human body, predominantly in the gut. This imbalance, often termed dysbiosis, is clinically significant because it compromises gut barrier function, affects nutrient absorption, and profoundly influences the metabolism and enterohepatic circulation of hormones. Microbiome Imbalance is a recognized contributor to systemic inflammation and various endocrine disorders.
Origin
The concept is rooted in the burgeoning field of microbiome research, which has revealed the symbiotic relationship between human hosts and their resident microorganisms. Imbalance reflects a deviation from the healthy, diverse eubiotic state. The connection to hormonal health stems from the discovery of the ‘estrobolome,’ the collection of gut bacteria that metabolizes estrogens.
Mechanism
Dysbiosis impairs the production of beneficial short-chain fatty acids (SCFAs) like butyrate, which are vital for colonocyte health and immune regulation. Furthermore, an imbalanced microbiome can lead to increased lipopolysaccharide (LPS) translocation, driving systemic inflammation and insulin resistance, which directly impacts the HPA axis and sex hormone binding globulin (SHBG) levels. Restoring microbial diversity and function is a critical mechanism for re-establishing hormonal homeostasis.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.